Forest-Schering license
Executive Summary
Schering will have rights to "certain of Forest's patented oral, controlled release" drug delivery technology under terms of a license agreement announced by Forest on Feb. 6. The agreement presumably is for Forest's Synchron system, for which Forest's patent claim was recently confirmed by the U.S. Patent Office after a challenge from Merrell Dow.